Humana divests minority stake in hospice provider Gentiva

Humana Inc.

Humana Inc.

HUM

0.00

June 10 (Reuters) - Humana HUM.N said on Wednesday it has agreed to sell all or substantially all of its minority stake in Gentiva, a provider of hospice and palliative care services, in a deal valuing the stake at about $900 million.

  • The stake will be sold to a group of investors, Humana said, without disclosing other financial terms.

  • Humana plans to use the proceeds for general corporate purposes and said the deal is not expected to affect its 2026 earnings.

  • The transaction is expected to close in the third quarter of 2026, subject to regulatory approvals and other closing conditions.

  • Gentiva provides hospice care and support for seriously ill patients at more than 430 locations in 35 states.

  • Humana's Gentiva stake stems from its 2021 Kindred at Home deal, after which it said it would sell non-core hospice and personal care businesses.

  • In 2022, Humana sold a majority stake in Kindred at Home's hospice and personal care units to private equity firm Clayton, Dubilier & Rice.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.